SymbNET Seminar

6 June 2022 (Mo)

12:00 WEST // 13:00 CEST

 

Speaker: Nassos Typas (EMBL)

Affiliation: Systems Microbiology Lab, EMBL, Germany

Title: Probing the interface of drugs and the human gut microbiome

Abstract: Drugs both impact the human gut microbiota and their bioavailability is modified by gut microbes. Here, I will be presenting recent highlights from coordinated efforts at EMBL to systematically map this drug-microbiome interface, to understand its impact on the gut microbiota and on drug efficacy, to address whether communities have emergent behaviours against drugs, and to discover ways to mitigate the collateral damage of drugs, and especially of antibiotics, on gut microbes.

If you are not registered for the SymbNET seminars, please register here.

 

SymbNET Seminars